1	Induction	Induction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	cytokine	cytokine	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	leukocytes	leukocyte	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	binding	binding	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	thrombin-stimulated	thrombin-stimulated	_	_	_	_	_	_	_
11	platelets	platelet	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Activated	activate	_	_	_	_	_	_	_
4	platelets	platelet	_	_	_	_	_	_	_
5	tether	tether	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	activate	activate	_	_	_	_	_	_	_
8	myeloid	myeloid	_	_	_	_	_	_	_
9	leukocytes	leukocyte	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	investigate	investigate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	potential	potential	_	_	_	_	_	_	_
5	relevance	relevance	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	mechanism	mechanism	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	acute	acute	_	_	_	_	_	_	_
11	myocardial	myocardial	_	_	_	_	_	_	_
12	infarction	infarction	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	AMI	AMI	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	we	we	_	_	_	_	_	_	_
18	examined	examine	_	_	_	_	_	_	_
19	cytokine	cytokine	_	_	_	_	_	_	_
20	induction	induction	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	leukocyte-platelet	leukocyte-platelet	_	_	_	_	_	_	_
23	adhesion	adhesion	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	occurrence	occurrence	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	leukocyte-platelet	leukocyte-platelet	_	_	_	_	_	_	_
29	conjugates	conjugate	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	patients	patient	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	AMI	AMI	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	AND	and	_	_	_	_	_	_	_
3	RESULTS	results	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	We	we	_	_	_	_	_	_	_
6	obtained	obtain	_	_	_	_	_	_	_
7	peripheral	peripheral	_	_	_	_	_	_	_
8	venous	venous	_	_	_	_	_	_	_
9	blood	blood	_	_	_	_	_	_	_
10	samples	sample	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	20	20	_	_	_	_	_	_	_
13	patients	patient	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	AMI	AMI	_	_	_	_	_	_	_
16	before	before	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	daily	daily	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	5	5	_	_	_	_	_	_	_
21	days	day	_	_	_	_	_	_	_
22	after	after	_	_	_	_	_	_	_
23	direct	direct	_	_	_	_	_	_	_
24	percutaneous	percutaneous	_	_	_	_	_	_	_
25	transluminal	transluminal	_	_	_	_	_	_	_
26	coronary	coronary	_	_	_	_	_	_	_
27	angioplasty	angioplasty	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	PTCA	PTCA	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	20	20	_	_	_	_	_	_	_
34	patients	patient	_	_	_	_	_	_	_
35	undergoing	undergo	_	_	_	_	_	_	_
36	elective	elective	_	_	_	_	_	_	_
37	PTCA	PTCA	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Throughout	throughout	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	period	period	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	CD41	cd41	_	_	_	_	_	_	_
7	immunofluorescence	immunofluorescence	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	leukocytes	leukocyte	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	flow	flow	_	_	_	_	_	_	_
12	cytometry	cytometry	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	revealed	reveal	_	_	_	_	_	_	_
15	increased	increase	_	_	_	_	_	_	_
16	leukocyte-platelet	leukocyte-platelet	_	_	_	_	_	_	_
17	adhesion	adhesion	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	AMI	AMI	_	_	_	_	_	_	_
22	compared	compare	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	control	control	_	_	_	_	_	_	_
25	patients	patient	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	mean	mean	_	_	_	_	_	_	_
28	+/-	+/-	_	_	_	_	_	_	_
29	SE	SE	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	fluorescence	fluorescence	_	_	_	_	_	_	_
32	[	[	_	_	_	_	_	_	_
33	channels	channel	_	_	_	_	_	_	_
34	]	]	_	_	_	_	_	_	_
35	before	before	_	_	_	_	_	_	_
36	PTCA	PTCA	_	_	_	_	_	_	_
37	:	:	_	_	_	_	_	_	_
38	77	77	_	_	_	_	_	_	_
39	+/-	+/-	_	_	_	_	_	_	_
40	16	16	_	_	_	_	_	_	_
41	versus	versus	_	_	_	_	_	_	_
42	35	35	_	_	_	_	_	_	_
43	+/-	+/-	_	_	_	_	_	_	_
44	9	9	_	_	_	_	_	_	_
45	;	;	_	_	_	_	_	_	_
46	P	p	_	_	_	_	_	_	_
47	=	=	_	_	_	_	_	_	_
48	.003	.003	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	vitro	vitro	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	thrombin-stimulated	thrombin-stimulated	_	_	_	_	_	_	_
5	fixed	fixed	_	_	_	_	_	_	_
6	platelets	platelet	_	_	_	_	_	_	_
7	bound	bind	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	neutrophils	neutrophil	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	monocytes	monocyte	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Within	within	_	_	_	_	_	_	_
2	2	2	_	_	_	_	_	_	_
3	hours	hour	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	this	this	_	_	_	_	_	_	_
6	resulted	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	increased	increase	_	_	_	_	_	_	_
9	mRNA	mrna	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	interleukin	interleukin	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	IL),1	il),1	_	_	_	_	_	_	_
14	beta	beta	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	IL-8	il-8	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	monocyte	monocyte	_	_	_	_	_	_	_
20	chemoattractant	chemoattractant	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	MCP)-1	mcp)-1	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	unfractionated	unfractionated	_	_	_	_	_	_	_
26	leukocytes	leukocyte	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	After	after	_	_	_	_	_	_	_
2	4	4	_	_	_	_	_	_	_
3	hours	hour	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	IL-1	il-1	_	_	_	_	_	_	_
6	beta	beta	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	IL-8	il-8	_	_	_	_	_	_	_
9	concentration	concentration	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	cell-free	cell-free	_	_	_	_	_	_	_
13	supernatant	supernatant	_	_	_	_	_	_	_
14	had	have	_	_	_	_	_	_	_
15	increased	increase	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	268	268	_	_	_	_	_	_	_
18	+/-	+/-	_	_	_	_	_	_	_
19	36	36	_	_	_	_	_	_	_
20	%	%	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	210	210	_	_	_	_	_	_	_
23	+/-	+/-	_	_	_	_	_	_	_
24	7	7	_	_	_	_	_	_	_
25	%	%	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	respectively	respectively	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	cellular	cellular	_	_	_	_	_	_	_
31	MCP-1	mcp-1	_	_	_	_	_	_	_
32	content	content	_	_	_	_	_	_	_
33	had	have	_	_	_	_	_	_	_
34	increased	increase	_	_	_	_	_	_	_
35	by	by	_	_	_	_	_	_	_
36	170	170	_	_	_	_	_	_	_
37	+/-	+/-	_	_	_	_	_	_	_
38	8	8	_	_	_	_	_	_	_
39	%	%	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Addition	addition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	activated	activate	_	_	_	_	_	_	_
4	platelets	platelet	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	adherent	adherent	_	_	_	_	_	_	_
7	monocytes	monocyte	_	_	_	_	_	_	_
8	had	have	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	similar	similar	_	_	_	_	_	_	_
11	effect	effect	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	associated	associate	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	factor-kappa	factor-kappa	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	binding	binding	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	anti-P	anti-p	_	_	_	_	_	_	_
6	selectin	selectin	_	_	_	_	_	_	_
7	antibodies	antibody	_	_	_	_	_	_	_
8	reduced	reduce	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	effect	effect	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	activated	activate	_	_	_	_	_	_	_
13	platelets	platelet	_	_	_	_	_	_	_
14	on	on	_	_	_	_	_	_	_
15	cytokine	cytokine	_	_	_	_	_	_	_
16	production	production	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	In	in	_	_	_	_	_	_	_
4	patients	patient	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	AMI	AMI	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	leukocyte-platelet	leukocyte-platelet	_	_	_	_	_	_	_
9	adhesion	adhesion	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	increased	increase	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	activated	activate	_	_	_	_	_	_	_
4	platelets	platelet	_	_	_	_	_	_	_
5	induces	induce	_	_	_	_	_	_	_
6	IL-1	il-1	_	_	_	_	_	_	_
7	beta	beta	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	IL-8	il-8	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	MCP-1	mcp-1	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	leukocytes	leukocyte	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	findings	finding	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	leukocyte-platelet	leukocyte-platelet	_	_	_	_	_	_	_
6	adhesion	adhesion	_	_	_	_	_	_	_
7	contributes	contribute	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	regulation	regulation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	inflammatory	inflammatory	_	_	_	_	_	_	_
13	responses	response	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	AMI	AMI	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

